Kent based sterile technology company FutureNova enjoys international success with first US sales with plans to scale up manufacturing to meet market demand from the health sector
News
Discovery Park Technology Fund invests in pioneering clinical development company, TC BioPharm (TCB) providing a launchpad for clinical trials of new treatments for cancer and viral infections